Citation tools

Morris, Michael et al "Phase Ib portion of the ACTION-1 phase Ib/3 trial of RYZ101 in gastroenteropancreatic neuroendocrine tumors (GEP-NET) progressing after 177Lu somatostatin analogue (SSA) therapy: safety and efficacy findings." Journal of Nuclear Medicine 65.supplement 2 (2024): 241428. Web. 25 May. 2025.

Citation Manager Formats